1. Home
  2. ALKS vs BCPC Comparison

ALKS vs BCPC Comparison

Compare ALKS & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • BCPC
  • Stock Information
  • Founded
  • ALKS 1987
  • BCPC 1967
  • Country
  • ALKS Ireland
  • BCPC United States
  • Employees
  • ALKS N/A
  • BCPC N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • BCPC Major Chemicals
  • Sector
  • ALKS Health Care
  • BCPC Industrials
  • Exchange
  • ALKS Nasdaq
  • BCPC Nasdaq
  • Market Cap
  • ALKS 4.8B
  • BCPC 5.0B
  • IPO Year
  • ALKS 1991
  • BCPC N/A
  • Fundamental
  • Price
  • ALKS $28.62
  • BCPC $155.48
  • Analyst Decision
  • ALKS Strong Buy
  • BCPC Strong Buy
  • Analyst Count
  • ALKS 13
  • BCPC 1
  • Target Price
  • ALKS $42.85
  • BCPC $190.00
  • AVG Volume (30 Days)
  • ALKS 3.1M
  • BCPC 165.4K
  • Earning Date
  • ALKS 10-28-2025
  • BCPC 10-21-2025
  • Dividend Yield
  • ALKS N/A
  • BCPC 0.56%
  • EPS Growth
  • ALKS 2.44
  • BCPC 22.48
  • EPS
  • ALKS 2.02
  • BCPC 4.57
  • Revenue
  • ALKS $1,521,338,000.00
  • BCPC $1,013,548,000.00
  • Revenue This Year
  • ALKS N/A
  • BCPC $10.31
  • Revenue Next Year
  • ALKS $24.60
  • BCPC $5.89
  • P/E Ratio
  • ALKS $14.21
  • BCPC $34.02
  • Revenue Growth
  • ALKS 1.08
  • BCPC 7.55
  • 52 Week Low
  • ALKS $25.17
  • BCPC $139.17
  • 52 Week High
  • ALKS $36.45
  • BCPC $185.96
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 40.47
  • BCPC 54.69
  • Support Level
  • ALKS $28.67
  • BCPC $151.97
  • Resistance Level
  • ALKS $31.74
  • BCPC $157.60
  • Average True Range (ATR)
  • ALKS 1.75
  • BCPC 3.03
  • MACD
  • ALKS -0.42
  • BCPC -0.18
  • Stochastic Oscillator
  • ALKS 12.80
  • BCPC 60.48

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: